Increases in hepatic APP alone may dramatically promote AD pathology, as a recent study demonstrated that overexpression of human APP in the liver increased Aβ levels in the periphery and the brain and promoted AD pathology in WT mice [132]. This evidence concerns the gene APP and Alzheimer disease.